Emulate INC., chip-R1 rigid chip, basic research kit 12 pack
Ended Purchase Order Awarded
- Contract number
- 75F40125P00095
- Awardee
-
Emulate Inc. UEI RPUADLQ52GD7
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $31,950
Award facts
- Opportunity
-
- “Brand Name or Equal” Emulate Inc. , Chip-R1 Rigid Chips, plus Preventive Maintenance and Repair Service on Emulate Modules Pre-Solicitation · 75F40125Q128406 · Posted Apr 21, 2025
- Contract value 100% obligated
- $31,950.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 3 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Boston, MA 02210, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a $31,950 purchase order to Emulate Inc. on June 18, 2025, for twelve Chip-R1 Rigid Chip basic research kits under a total small business set-aside designation. The contract, which extends to October 16, 2025, represents a firm fixed price procurement of the company's organ-on-chip technology. Emulate Inc., headquartered in Boston, Massachusetts, specializes in microphysiological systems that replicate human organ functions to support advanced biomedical research and regulatory science initiatives. The award follows an FDA sources sought announcement from the National Center for Toxicological Research Division of Neurotoxicology, which had solicited capability statements for Chip-R1 rigid chips and associated maintenance services designed to support brain-chip research modeling cerebral blood flow for neurotoxicity evaluation.
This contract reflects the FDA's strategic investment in alternatives to traditional animal testing and advancement of preclinical drug development screening methods. Emulate's organ-on-chip technology has become increasingly important to federal agencies seeking to improve regulatory decision-making through more accurate human-relevant modeling. The award builds upon the company's established relationship with the FDA and other agencies within the Department of Health and Human Services, including the National Institutes of Health, which have regularly procured Emulate's sophisticated bioengineered systems. The small business set-aside designation underscores the government's commitment to supporting innovative biotechnology firms developing transformative research tools.
Quick answers
Who was awarded contract 75F40125P00095?
75F40125P00095 was awarded to Emulate Inc. by Food and Drug Administration (Department of Health and Human Services) on June 18, 2025.
How much is contract 75F40125P00095 worth?
The government has obligated $31,950 on 75F40125P00095.
Was contract 75F40125P00095 competed?
The extent of competition for 75F40125P00095 was competed under sap. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award